Skip to main content
. 2024 Jan 18;9(1):14. doi: 10.3390/geriatrics9010014

Table 2.

Characteristics of the study sample: nonagenarians (94–99 years), and centenarians (100 years and over). Subgroups of women and participants aged 94–99 years served as comparators in statistical analyses.

All
(n = 289)
Women
(n = 225)
Men
(n = 64)
94–99 Years
(n = 202)
≥100 Years
(n = 87)
Age [yrs ± SD] 98.3 ± 2.6 98.4 ± 2.5 98.2 ± 2.8 96.9 ± 1.5 101.5 ± 1.5 ***
Living at home [n (%)] 239 (82.7) 180 (80.0) 59 (92.2) 169 (83.7) 70 (80.5)
Living in an institution [n (%)] 50 (17.3) 45 (20.0) 5 (7.8) * 33 (16.3) 17 (19.5)
Education level
<8 yrs [n (%)] 88 (37.9) 77 (42.5) 11 (21.6) 67 (39.9) 21 (32.8)
8–13 yrs [n (%)] 92 (39.7) 71 (39.2) 21 (41.2) 64 (38.1) 28 (43.8)
>13 yrs [n (%)] 52 (22.4) 33 (18.2) 19 (37.3) ** 37 (22.0) 15 (23.4)
Missing data [n] 57 44 13 34 23
ADL score 3.8 ± 1.8 3.6 ± 1.8 4.4 ± 1.8 ** 4.1 ± 1.8 3.1 ± 1.8 ***
Dependent [n (%)] 67 (23.2) 55 (24.4) 12 (18.8) 36 (17.8) 31 (35.6)
Partially dependent [n (%)] 102 (35.3) 90 (40.0) 12 (18.8) 65 (32.2) 37 (42.5)
Independent [n (%)] 120 (41.5) 80 (35.6) 40 (62.5) *** 101 (50.0) 19 (21.8) ***
IADL score 13.6 ± 4.9 13.1 ± 4.6 15.2 ± 5.5 ** 14.4 ± 5.0 11.6 ± 4.2 ***
Dependent [n (%)] 235 (81.3) 190 (84.4) 45 (70.3) 156 (77.2) 79 (90.8)
Partially dependent [n (%)] 44 (15.2) 31 (13.8) 13 (20.3) 37 (18.3) 7 (8.0)
Independent [n (%)] 10 (3.5) 4 (1.8) 6 (9.4) ** 9 (4.5) 1 (1.1) *
MMSE score 22 (15–26) 21 (14–25) 24 (20–26) ** 23 (18–26) 17 (11–23) ***
No dementia [n (%)] 119 (42.0) 84 (38.4) 35 (54.7) 100 (49.8) 19 (23.2)
Mild/moderate dementia [n (%)] 126 (44.5) 99 (45.2) 27 (42.2) 82 (40.8) 44 (53.7)
Severe dementia [n (%)] 38 (13.4) 36 (16.4) 2 (3.1) ** 19 (9.5) 19 (23.2) ***
Missing data [n] 6 6 0 1 5
Vision impairment
No impairment [n (%)] 119 (41.5) 82 (36.8) 37 (57.8) 97 (48.5) 22 (25.3)
Mild impairment [n (%)] 50 (17.4) 42 (18.8) 8 (12.5) 34 (17.0) 16 (18.4)
Moderate impairment [n (%)] 73 (25.4) 61 (27.4) 12 (18.8) 49 (24.5) 24 (27.6)
Severe impairment [n (%)] 45 (15.7) 38 (17.0) 7 (10.9) * 20 (10.0) 25 (28.7) ***
Missing data [n] 2 2 0 2 0
Hearing impairment
No impairment [n (%)] 84 (30.2) 61 (28.5) 23 (35.9) 65 (32.8) 19 (23.8)
Moderate impairment [n (%)] 134 (48.2) 107 (50.0) 27 (42.2) 92 (46.5) 42 (52.5)
Severe impairment [n (%)] 60 (21.6) 46 (21.5) 14 (21.9) 41 (20.7) 19 (23.8)
Missing data [n] 11 11 0 4 7
CVD [n (%)] 185 (64.9) 144 (64.9) 41 (65.1) 130 (65.3) 55 (64.0)
Missing data [n] 4 3 1 3 1
Hypertension [n (%)] 193 (66.8) 154 (68.4) 39 (60.9) 140 (69.3) 53 (60.9)
Past stroke [n (%)] 33 (12.1) 26 (12.2) 7 (11.7) 18 (9.5) 15 (18.1) *
Missing data [n] 16 12 4 12 4
Diabetes [n (%)] 40 (13.9) 30 (13.5) 10 (15.6) 34 (17.0) 6 (6.9) *
Missing data [n] 2 2 0 2 0
Arthritis [n (%)] 77 (26.6) 69 (30.7) 8 (12.5) ** 52 (25.7) 25 (28.7)
Osteoporosis [n (%)] 54 (19.9) 45 (21.2) 9 (15.0) 44 (23.0) 10 (12.3) *
Missing data [n] 17 13 4 11 6
COPD [n (%)] 7 (2.4) 5 (2.2) 2 (3.1) 5 (2.5) 2 (2.3)
Missing data [n] 1 1 0 1 0

* p < 0.05; ** p < 0.01; *** p < 0.001. Abbreviations: yrs—years; SD—standard deviation; ADL—activities of daily living; IADL—instrumental ADL; MMSE—Mini-Mental State Examination; CVD—cardiovascular disease; COPD—chronic obstructive pulmonary disease; Q1–Q3—interquartile range.